Vol 10, N°4
Remission in depression
Past issues
Contributors
How to publish
Contributions and comments
Home
Alert
To print this page in good conditions, please select the "Landscape" mode of your printer.
|
Select and print
|
linicians working with depressed patients are
often confronted with the unsatisfactory degree of remis-
sion that current therapeutic strategies yield, and with the
vexing problems of relapse and recurrence.
1
In clinical
medicine, the term recovery connotes the act of regain-
ing or returning toward a normal or usual state of health.
However, there is a lack of consensus regarding the use
of this term (which may indicate both a process and a
state), as well as of the related word remission.This lat-
ter indicates a temporary abatement of the symptoms of
a disease. Such ambiguities reflect on the concepts of
relapse (the return of a disease after its apparent cessa-
tion) and recurrence (the return of symptoms after a
remission).
In an attempt to overcome these flaws, Frank et al
2
pro-
posed a set of definitions which they referred to as lon-
gitudinal studies of mood disorders, but may entail more
general applicability in psychiatry. Remission (which is
differentiated into partial and full remission) is a rela-
tively brief period during which an improvement of suf-
ficient magnitude is observed and the individual no
longer meets syndromal criteria for the disorder.
Recovery implies a more sustained remission, and raises
the possibility that treatment can be discontinued or
prolonged with the aim of prevention. Relapse is a
return of symptoms satisfying the full syndromal crite-
ria during the period of remission, whereas recurrence
C l i n i c a l r e s e a r c h
C
Copyright © 2008 LLS SAS. All rights reserved
www.dialogues-cns.org
Psychosocial determinants of
recovery in depression
Giovanni A. Fava, MD; Dalila Visani, PsyD
Keywords:
depression; recovery; staging; sequential model; psychological well-
being
Author affiliations:
Department of Psychology, University of Bologna, Italy
(Giovanni A. Fava, Dalila Visani); Department of Psychiatry, State University of
New York at Buffalo, Buffalo, NY (Giovanni A. Fava)
Address for correspondence:
Prof Giovanni A. Fava, Department of Psychology,
University of Bologna, Viale Berti Pichat 5, 40127 Bologna, Italy
(e-mail: giovanniandrea.fava@unibo.it)
There is a growing body of literature on residual symp-
toms after apparently successful treatment. The strong
prognostic value of subthreshold symptomatology upon
remission and the relationship between residual and pro-
dromal symptomatology (the rollback phenomenon) have
been outlined. Most residual symptoms also occur in the
prodromal phase of depression and may progress to
become prodromes of relapse. These findings entail
important implications. It is necessary to closely monitor
the patient throughout the different phases of illness and
to assess the quality and extent of residual symptoms. A
more stringent definition of recovery, which is not limited
to symptomatic assessment, but includes psychological
well-being, seems to be necessary. New therapeutic strate-
gies for improving the level of remission, such as treat-
ment of residual symptoms that progress to become pro-
dromes of relapse and/or increasing psychological
well-being, appear to yield more lasting benefits. The
sequential model may provide room for innovative treat-
ment approaches, including the use of drugs for specifi-
cally addressing residual symptoms. As occurs in other
medical disorders (such as diabetes and hypertension), the
active role of the patient in achieving recovery (self-ther-
apy homework) should be pursued.
© 2008, LLS SAS
Dialogues Clin Neurosci.
2008;10:461-472.